Clorox Reports 19% Decline in Net Sales for First Quarter of Fiscal Year 2026

The Clorox Company reported a significant decline in financial performance for the first quarter of fiscal year 2026, ending September 30, 2025. The company recorded net sales of $1.429 billion, a decrease of 19% compared to $1.762 billion in the same period last year. This decline was attributed to lower shipment volumes following a surge in shipments related to the transition to a new enterprise resource planning (ERP) system in the previous quarter. Gross profit also fell to $596 million, down 26% from $807 million, resulting in a gross margin of 41.7%, a decrease of 410 basis points from the prior year.

In terms of profitability, net earnings attributable to Clorox were $80 million, or $0.65 per diluted share, down from $99 million, or $0.80 per diluted share, in the prior year. The effective tax rate on earnings decreased to 23.4% from 41.8%, primarily due to the nondeductibility of a loss on the divestiture of the Better Health Vitamins, Minerals, and Supplements business in the previous year. The company also reported a loss on divestiture of $118 million in the prior period, which did not recur in the current quarter.

Operationally, Clorox continues to face challenges, including inflationary pressures and macroeconomic uncertainties that have affected consumer spending. The company has been actively working on its digital transformation, with an investment of approximately $580 million expected to enhance operational efficiencies and support long-term growth. The transition to the new ERP system is ongoing, and while it has caused some disruptions, the company remains on track for completion within the fiscal year.

Clorox's strategic focus includes maintaining its market position in key segments such as Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment generated $565 million in sales, down 19% year-over-year, while the Household segment also saw a 19% decline to $362 million. The Lifestyle segment experienced a more pronounced drop of 23%, with sales of $245 million. Despite these challenges, Clorox continues to invest in its brands and capabilities, aiming for consistent, profitable growth in the future.

Looking ahead, Clorox anticipates a volatile operating environment, influenced by ongoing geopolitical tensions and inflationary pressures. The company plans to continue its investments in brand development and operational capabilities while navigating the complexities of the current market landscape. Clorox remains committed to generating positive cash flows to support its obligations, including the upcoming purchase of Procter & Gamble's 20% interest in the Glad business, which is due in January 2026.